CombiMatrix's Q1 Revenues Drop 13 Percent as Firm Focuses on Dx Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix reported after the close of the market Tuesday that its first-quarter revenues fell 13 percent, with its government contracts and products revenues both declining year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.